Anastassia Komarova

Title: Innovations by Anastassia Komarova

Introduction

Anastassia Komarova is an accomplished inventor based in Arcueil, France. She has made significant contributions to the field of infectious disease prevention, particularly through her innovative work on multivalent vaccines. Her research focuses on the development of compositions and methods that utilize measles virus defective interfering particles.

Latest Patents

Anastassia holds 1 patent for her invention titled "Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases." This invention is aimed at enhancing the prevention or treatment of infectious diseases. The patent details the characterization of 5' copy-back DI-RNAs produced by recombinant measles virus strains, including rMV-based vaccines and wild-type MV. The efficiency of these DI-RNAs in different cell types was compared, and for the first time, specific binding of 5' copy-back DI-RNAs to RIG-I, MDA5, and LGP2 was assessed, linking it to functional outcomes in type-I IFN signaling.

Career Highlights

Throughout her career, Anastassia has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. Her research has contributed to advancements in vaccine development and the understanding of immune responses to viral infections.

Collaborations

Anastassia has collaborated with notable professionals in her field, including her coworker Marie Mura. Their joint efforts have furthered research in the area of infectious diseases and vaccine innovation.

Conclusion

Anastassia Komarova's work exemplifies the impact of innovative research in the prevention of infectious diseases. Her contributions to the field of multivalent vaccines are significant and continue to influence future developments in vaccine technology.